原位复合法制备层状结构的壳聚糖/羟基磷灰石纳米材料

用原位复合法制备了高性能的壳聚糖/羟基磷灰石(CS/HA)纳米复合材料.用预先沉积的壳聚糖膜将含有羟基磷灰石前驱体的壳聚糖溶液与凝固液隔离,同时控制壳聚糖沉积与羟基磷灰石前驱体转化为羟基磷灰石的过程,使其缓慢且有序地进行.当pH值改变时,质子化的壳聚糖分子链在负电层诱导下有序沉积并形成层状结构与羟基磷灰石原位生成CS/HA,并实现二者分子级复合.XRD和TEM测试证实原位生成的磷酸盐是羟基磷灰石,且其颗粒长约为100nm,宽30～50nm.SEM结果表明,用原位复合法制备的材料具有层状结构,CS/HA(质量比100/5)纳米复合材料弯曲强度高达86MPa,比松质骨的高3～4倍,相当于密质骨的1/2,有望用于可承重部位的组织修复材料.     

脉冲电化学沉积法制备羟基磷灰石/壳聚糖复合涂层的研究

采用脉冲电化学沉积法在钛金属表面制备出羟基磷灰石/壳聚糖(HA/CS)复合涂层,实现CS与HA在微观尺寸上的复合与杂化.比较了脉冲电位与恒电位模式下复合涂层的形成,研究了电位高低及壳聚糖浓度对复合涂层性能的影响.结果表明,与恒电位模式比较,脉冲电位下制备的涂层较均匀、结晶性好、CS含量高,并且HA与CS杂化程度高.脉冲...     

原位沉析法制备可吸收壳聚糖/羟基磷灰石棒材

利用原位沉析法制备出一种以壳聚糖 (Chitosan ,CS)为基体 ,羟基磷灰石 (Hydroxyapatite,HA)为填料的新颖的复合材料 ,系统研究了HA含量对复合材料的力学性能和吸水率的影响 .CS HA的弯曲强度为 6 7 8(MPa) ,弯曲模量为 3 3(GPa) ,剪切强度为 2 1 2 (MPa) ,压缩强度为 4 7 8(MPa) ,均比人的自然骨高 2～ 3倍 ,基本满足了作为骨折内固定材料的力学性能的要求 .HA加入到CS使CS HA复合材料的吸水率下降 ,有助于延缓其力学强度在湿态环境下的衰减     

多孔载药纳米羟基磷灰石/聚酰胺/壳聚糖复合材料的制备与性能

以纳米羟基磷灰石(n-HA)、聚酰胺(PA)、壳聚糖(CS)为原料,以聚乙烯吡咯烷酮(PVP)与氯化钠(Na Cl)为致孔剂采用溶液共混法和粒子致孔法,载入抗生素红霉素(EM),研制一种新型多孔载药纳米羟基磷灰石/聚酰胺/壳聚糖/红霉素复合骨组织修复材料。研究了其孔隙率、抗压强度、X射线衍射谱图、红外光谱图、SEM和药物释放曲线,探讨了CS含量及红霉素释放量对材料性能的影响。结果表明,当PVA/Na Cl为1:6时,材料总孔隙率为72%和抗压强度为0.71MPa,扫描电镜显示多孔n-HA/PA/CS复合材料孔的直径在100~500μm之间,适合血管、骨组织的长入以及营养物质的运输。当CS的含量从0增到30%时复合材料药物的释放量从41.6%增到82.4%,表明可降解材料CS的加入有利于药物溶出。     

钛基多孔HA/SiO2复合涂层的制备及性能研究

为了制得表面多孔且与基材结合强度高的羟基磷灰石(HA)涂层,实验中以正丁醇为分散介质,以SiO2粉末为添加剂,纯钛片为基材,电泳沉积制备羟基磷灰石/二氧化硅/壳聚糖/(HA/SiO2/CS)复合涂层,经后续热处理得到多孔HA/SiO2复合涂层,采用扫描电镜(SEM)、傅立叶红外光谱仪(FT-IR)、X射线衍射仪(XRD)、万能材料试验机对涂层的表面形貌、组成、结构和结合强度进行测试和表征,并通过模拟体液(SBF)浸泡法对复合涂层的生物活性进行评价.结果表明:当悬浮液中的HA/SiO2/CS质量比为1∶1∶1时,制得的HA/SiO2/CS涂层经700℃热处理后获得的HA/SiO2复合涂层孔洞分布均匀,大孔孔径在10～15μm,小孔孔径在1～5μm;涂层与基材的结合强度达到25.5 MPa;多孔HA/SiO2复合涂层在SBF中浸泡7 d后,涂层表面碳磷灰石化;说明实验中添加SiO2所制得的多孔HA/SiO2复合涂层与钛基材结合强度高,且具有良好的生物活性.     

原位沉析法制备磁性氧化铁羟基磷灰石/壳聚糖棒材

首先通过化学沉淀法制备磁性氧化铁羟基磷灰石(Fe3O4/HA),然后以壳聚糖(CS)为基体,利用原位沉析法将Fe3O4/HA与CS复合,制得磁性Fe3O4/HA/CS复合材料.经XRD、粒径分布和PPMS测试,结果表明了Fe3O4/HA复合物的生成.系统研究了磁性Fe3O4/HA/CS棒材力学性能的影响因素,最终确定Fe3O4与HA质量比为3∶17,磁性Fe3O4/HA与CS质量比为9∶91时,棒材的力学性能最优,弯曲强度可达到87.0 MPa,弯曲模量1.57 GPa.     

羟基磷灰石/氧化铁复合涂层的制备及其诱导骨生长的生物活性

用电泳沉积法制得羟基磷灰石/壳聚糖/氧化铁(HA/CS/Fe2O3)复合涂层,经700 ℃烧结处理得到HA/Fe2O3复合涂层。 通过SEM、EDS、XRD、FT-IR、电化学和万能材料试验机等对复合涂层的表面形貌、物相组成、抗腐蚀性和结合强度进行了表征和测试,最后采用1.5SBF浸泡法对复合涂层的生物活性进行了评价。 结果表明,当悬浮液中的HA、CS与Fe2O3质量比为100∶100∶1时,所制得的HA/Fe2O3复合涂层表面粗糙,抗腐蚀性强,具有良好的诱导骨生长生物活性,基体与复合涂层结合强度可达27.5 MPa。     

化学-物理法制备聚乙烯醇/壳聚糖/纳米羟基磷灰石复合水凝胶及其性能

采用化学-物理交联法制备了聚乙烯醇/壳聚糖/纳米羟基磷灰石(PVA/CS/n-HA)复合水凝胶材料。通过对比其含水率、拉伸强度、红外光谱和TG谱图,探讨了PVA含量及戊二醛加入量对材料性能的影响。结果表明,m(PVA)∶m(CS+n-HA)=5∶1,戊二醛质量分数为2%时,复合水凝胶材料具有较好的综合性能:含水率为82.0%、拉伸强度为2.14 MPa、断裂伸长率为343.26%;同步热分析表明,25~140℃,仅存在水分的蒸发,直至360℃材料才发生分解,说明材料的热稳定性良好;红外分析表明,CS与戊二醛发生了交联反应。     

磷酸化壳聚糖膜的仿生复合修饰

仿生构建羟基磷灰石/壳聚糖复合材料是制备骨修复材料的一条有效途径.以甲醛和磷酸为反应试剂,采用均相反应法制备出壳聚糖(CS)的磷酸化衍生物-甲基磷酸化壳聚糖(NPCS).红外光谱、X射线光电子能谱分析结果表明,改性后的CS分子结构和元素组成发生显著变化,偶合等离子体发射光谱测试显示NPCS的取代度可达到0.5左右.用模拟体液(SBF)处理CS和NPCS膜,扫描电镜(SEM)观察和能量色散X射线分析表明,NPCS膜表面沉积了磷酸钙盐.由X射线衍射分析得知,NPCS膜表面形成的是低结晶度的羟基磷灰石(HA).接触角测试结果表明,经改性或修饰后,材料表面的亲水性明显提高.     

HA/CuO/SrCO3梯度复合涂层的制备及体外生物活性

在羟基磷灰石(HA)悬浮液中, 以正丁醇为分散介质, 三乙醇胺为乳化剂, 成骨微量元素化合物CuO 和SrCO₃作为添加剂, Ti片为基材, 壳聚糖(CS)为造孔剂, 依次通过区带电泳分布并在反向电场作用下电 泳沉积, 得到HA/CS/CuO/SrCO₃复合涂层, 经700 ℃高温煅烧2 h后, 制得HA/CuO/SrCO₃复合涂层. 通过X射线衍射(XRD)、 傅里叶变换红外光谱(FTIR)、 场发射扫描电子显微镜(FESEM)、 能量色散光谱仪(EDS)、 劳埃德万能材料试验机、 电化学工作站、 模拟体液培养和抑菌实验等手段对复合涂层进行测试与表征. 结果表明, Ca, Cu和Sr 元素含量在HA/CuO/SrCO₃复合涂层的径向上均呈现梯度分布; 复合涂层与钛基材的结合强度达33.0 MPa; 循环伏安(CV)曲线和Tafel极化曲线测试表明, 复合涂层在N-2-羟乙基哌嗪-N′-2-乙磺酸(HEPES)模拟体液(H-SBF)中电化学性能稳定, 耐腐蚀性较强; 在H-SBF中培养24 d后, 复合涂层表面完全碳磷灰石化; 抑菌实验发现, 复合涂层粉末对大肠杆菌和金黄色葡萄球菌的抑菌率分别为81.82%和71.86%.     

壳聚糖微球负载的己二胺型聚酰胺-胺树状大分子的制备及对胆红素的吸附

通过反相悬浮反应制备了戊二醛交联的壳聚糖微球。以所制备的壳聚糖微球为载体,合成了己二胺型低代数聚酰胺-胺（Polyamidoamine,简称PAMAM）树枝状大分子（Genaration≤3）。考察了该微球在生理条件下对水溶液中胆红素的吸附行为,以及溶液的pH值,离子强度,温度,胆红素初始浓度,牛血清白蛋白等因素对吸附的影响。结果表明,吸附剂对胆红素具有良好的吸附性能,CS-G2.0,CS-G3.0,CS-G1.0,CS-G0和CS微球的平衡吸附率分别为94.61%,93.44%,92.97%,86.47%,52.38%,CS-G1.0-G3.0微球在0.5h吸附率已经超过70%,1h基本接近平衡,对胆红素的吸附量高达42.78mg/g。     

Loading behavior of {chitosan/hyaluronic acid}n layer-by-layer assembly films toward myoglobin: an electrochemical study

When {CS/HA}n layer-by-layer films assembled by oppositely charged chitosan (CS) and hyaluronic acid (HA) were immersed in myoglobin (Mb) solution at pH 5.0, Mb was gradually loaded into the {CS/HA}n films, designated as {CS/HA}n-Mb. The cyclic voltammetric (CV) peak pair of Mb FeIII/FeII redox couple for {CS/HA}n-Mb films on pyrolytic graphite (PG) electrodes was used to investigate the loading behavior of {CS/HA}n films toward Mb. The various influencing factors, such as the number of bilayers (n), the pH of Mb loading solution, and the ionic strength of solution, were investigated by different electrochemical methods and other techniques. The results showed that the main driving force for the bulk loading of Mb was most probably the electrostatic interaction between oppositely charged Mb in solution and HA in the films, while other interactions such as hydrogen bonding and hydrophobic interaction may also play an important role. Other polyelectrolyte multilayer (PEM) films with different components were compared with {CS/HA}n films in permeability and Mb loading, and electroactive probes with different size and surface charge were compared in their incorporation into PEM films. The results suggest that due to the unique structure of CS and HA, {CS/HA}n films with relatively low charge density are packed more loosely and more easily swelled by water, and have better permeability, which may lead to the higher loading amount and shorter loading time for Mb. The protein-loaded PEM films provide a new route to immobilize redox proteins on electrodes and realize the direct electrochemistry of the proteins.     

新型介孔羟基磷灰石/壳聚糖-万古霉素药物释放系统复合材料的制备及体外抗菌和成骨能力

采用冷冻干燥法合成了介孔羟基磷灰石(HA)/壳聚糖(CS)-万古霉素(VCM)药物释放系统复合材料, 利用SEM, XRD和FTIR等方法对材料进行了表征. 结果证实CS与HA混合复合材料具有良好的孔径和孔隙率, 万古霉素吸附于复合材料的表面和内部. 细胞毒性实验[噻唑蓝(MTT)比色法]结果表明, 材料可以促进成骨细胞增殖且具有良好的细胞相容性. 体外抑菌实验结果证实此材料可长时间抑制耐甲氧西林金葡菌(MRSA)的生长, 具有良好的抑菌和杀菌能力. 细胞黏附实验结果表明, 成骨细胞附着于材料表面增殖并通过孔道延伸. 实时聚合酶链式反应(RT-PCR)实验结果表明, 在成骨相关标志产物胶原蛋白-1(COL-1)及骨形态发生蛋白-2(BMP-2)基因上均有较高的表达, 表明材料在体外可以促进成骨细胞生长, 具有良好的成骨能力.     

造孔剂对电泳沉积制备多孔HA涂层及其生物活性的影响

采用水热法制得的羟基磷灰石(HA)纳米粉体,分别与造孔剂葡萄糖(Glu)、壳聚糖(CS)、炭粉(C)3种微粒(＜38.5 μm)配置成质量比1∶1的悬浮液,电泳沉积 烧结制备钛基多孔HA涂层,并对制得的3种多孔HA涂层在模拟体液浸泡前后的表面形貌、化学组成及物相变化进行表征。 结果表明,经700 ℃烧结处理后制得的3种多孔HA涂层在1.5倍人体模拟体液中浸泡5 d后,多孔HA涂层表面均被层状生长的碳磷灰石颗粒完全覆盖,颗粒直径在5~25 μm,说明这些多孔HA涂层均具有良好的生物活性。 其中以CS为造孔剂制得的多孔HA涂层结合强度最高,达19.5 MPa,有望开发成为新型的人骨植入生物陶瓷材料。     

Thermal behavior of nickel–metal hydride battery during charging at a wide range of ambient temperatures

In this study, hydoxyapatite (HA) prepared from calcined bovine bone was studied. Two methods were used for HA sintering: conventional sintering (CS) and microwave sintering (MS). HA was obtained by calcination of bovine bone at 800 °C for 4 h followed by wet ball milling. Afterwards, the powder was compacted under 75 MPa and sintered for 2 h at different temperatures, from 1050 to 1200 °C. It has been found that the bulk density of HA increases by increasing sintering temperature when both CS and MS were used. Nevertheless, at the same temperature and for a shorter time (15 min), the HA sintered by microwave were characterised by a density relatively higher than that of sintered by conventional furnace. For example, at 1100 °C the bulk densities of samples using CS and MS were about 2.49 (for 120 min) and 2.93 (for 15 min) g/cm³, respectively. Furthermore, a near theoretical density (98.6%) was obtained when HA samples were sintered at 1200 °C for 15 min only but using the proposed MS, which was much higher than that (89.7%) of HA samples sintered at the same temperature for longer holding time (120 min). Besides this, the X-ray analyses have shown that heat-treatment, using these two processes, has lead to HA decomposition into tricalcium phosphate and/or tetracalcium phosphate.     

Variations in content and structure of glycosaminoglycans of the vitreous gel from different mammalian species

The vitreous of all species is composed of essentially the same type of extracellular matrix macromolecules organized to a transparent gel. In this study, the composition and fi ne chemical structure of the glycosaminoglycans (GAGs) in the vitreous gel from sheep and goat were determined and compared with those of human and pig vitreous gels. The results showed that, in all examined species; hyaluronan (HA) was the predominant GAG, whereas chondroitin sulphate (CS) was the minor one. In the vitreous gel of the most relative species, i.e. sheep and goat, higher amounts of both of HA and CS were estimated as compared with pig and human tissues. The distribution of hydrodynamic sizes of HA and CS was significantly differed among different species. All HA preparations consisted of molecules with great variability in hydrodynamic sizes. The relative proportions of the large HA molecules (size >1.8 x 10(6) kDa) were significantly higher in sheep and goat as compared with human and pig vitreous gel. The length of CS chains was also of larger size in sheep and goat (50 and 58 kDa, respectively) than the respective chains in human and pig vitreous gel (38 and 28 kDa, respectively). The sulphation patterns of CS preparations were determined following enzymic treatments, HPLC and capillary electrophoretic analyses. The human vitreous-derived CS chains showed quite different sulphation profile than that of CS isolated from other species, since 4-sulphated disaccharides were identified as the dominant moiety. In conclusion, significant compositional and structural variations between the vitreous matrixes of different species at the GAG level were identified. The functional significance of these species-dependent variations is discussed.     

Effect of immobilization of polysaccharides on the biocompatibility of poly(butyleneadipate‐co‐terephthalate) films

Aiming to improve the hydrophilicity, antibacterial activity, cytocompatibility, and hemocompatibility of poly(butyleneadipate‐co‐terephthalate) (PBAT) films, PBAT films were treated with ozone, grafted with chitosan (CS), and followed by covalent immobilization of either heparin (HEP) or hyaluronic acid (HA). The surface graft density of modified PBAT films was detected by X‐ray photoelectron spectroscopy (XPS) and dyeing. The surface roughness of PBAT films was measured using an atomic force microscope (AFM). After immobilizing CS, PBAT films acquired antibacterial activity against Staphylococcus aureus and Escherichia coli. The adsorption of human serum albumin (HSA) and human plasma fibrinogen (HPF) on PBAT–CS–HEP and PBAT–CS–HA films was lower compared to that of native PBAT. Moreover, HEP immobilization could effectively reduce platelet adhesion and prolong the blood coagulation time, thereby improving the blood compatibility of PBAT. In addition, the growth of L929 fibroblasts was improved for HEP or HA immobilized PBAT, suggesting this surface modification was non‐cytotoxic. Furthermore, PBAT–CS–HEP and PBAT–CS–HA exhibited higher cell proliferation than native PBAT. Copyright © 2009 John Wiley & Sons, Ltd.